window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : August 13, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Featured

  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Vaderis raises $152M and starts Phase 3 trial of engasertib in HHT

    Vaderis Therapeutics has raised $152M and started a global Phase [...]

    August 12, 2026
  • Central Nervous System,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    AC Immune gets FDA Fast Track for Parkinson’s immunotherapy ACI-7104

    AC Immune has received FDA Fast Track designation and IND [...]

    August 12, 2026
  • Biotech & Pharma Business,Digital & Data,Genomics and sequencing,Research & Development,Therapeutic Areas

    Bios Life launches with $25M funding and Tempus cancer AI partnership

    Bios Life has emerged from stealth with $25M in seed [...]

    August 12, 2026
  • Advanced Therapies,Central Nervous System,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Oncoinvent publishes Radspherin dosimetry data in Journal of Nuclear Medicine

    Oncoinvent has published Phase 1 dosimetry data for Radspherin in [...]

    August 12, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics

    FDA issues Complete Response Letter for ITM-11 over manufacturing issues

    The FDA has issued a Complete Response Letter for ITM-11, [...]

    August 11, 2026
  • Digital & Data,Drug Discovery & Development,Research & Development

    Novo Nordisk and AWS launch London AI hub to accelerate drug discovery

    Novo Nordisk and AWS have launched a London co-innovation hub [...]

    August 11, 2026
  • Advanced Therapies,Drug Discovery & Development,Genomics and sequencing

    Broken String Biosciences launches BaseMap ABE for genome-wide off-target analysis

    Broken String Biosciences has launched BaseMap ABE, a platform designed [...]

    August 10, 2026
  • Digital & Data,Drug Discovery & Development,Manufacturing & Supply Chain,Research & Development

    European consortium demonstrates continuous API manufacturing platform

    A European consortium has validated a continuous manufacturing platform designed [...]

    August 7, 2026
  • Central Nervous System,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development

    BioVie reports Phase 2 Parkinson’s trial results for bezisterim

    BioVie has reported topline results from a Phase 2 trial [...]

    August 7, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Research & Development

    LifeMine raises $263 million to advance transplant rejection therapy into Phase 2

    Biotech company LifeMine Therapeutics has raised $263 million to support [...]

    August 7, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Acarizax accepted for house dust mite allergy treatment in NHS Scotland
    Categories: Clinical & Regulatory
  • Broken String Biosciences launches BaseMap ABE for genome-wide off-target analysis
    Categories: Advanced Therapies, Drug Discovery & Development, Genomics and sequencing
  • AstronauTx exercises Saniona option for neurological disease candidate
    Categories: Central Nervous System, Drug Discovery & Development, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top